Testing effectiveness (Phase 2)Study completedNCT00896532
What this trial is testing
Romosozumab (AMG 785) in Postmenopausal Women With Low Bone Mineral Density
Who this might be right for
Low Bone Mineral DensityPostmenopausal Osteoporosis
Amgen 419